GlassScriptPhysician profile
Bodrie Jensen
NPI 1053936617
$4,706.82
in general payments reported to CMS, 2019-2025
10 companies · $1,574 in 2025
The $1,574 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,208 · 2022: $1,465 · 2023: $212 · 2024: $248 · 2025: $1,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,022 · Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,021.90 |
| Food and Beverage | $1,012.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,431.56 | 2021-2023 | |
| Arthrex, INC. | $978.18 | 2025 | |
| Legacy Ortho LLC | $303.59 | 2025 | |
| Zimmer Biomet Holdings, INC. | $252.44 | 2025 | Tapestry, Juggerstitch, Juggerknotless Soft Anchor |
| Stryker Corporation | $225.36 | 2022-2025 | Mako, Triathlon, Aequalis Perform |
| Depuy Synthes Sales INC. | $139.09 | 2024 | Na |
| Integra Lifesciences Corporation | $122.35 | 2022 | |
| Heron Therapeutics, INC. | $117.93 | 2023 | Zynrelef |
| Smith+Nephew, INC. | $107.87 | 2023-2024 | Trigen Intertan, Evos, Maverick |
| Pacira Pharmaceuticals Incorporated | $28.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bodrie Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.